TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Sensitivity and specificity of the nomogram model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Externalizing behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adaptive skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Parental desire for continuous monitoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: OSS (O'Leary-Sant Pain Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS pain scale improvement (VAS ≥ 3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in spherical equivalent (SE) from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vision from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response time improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment on the donor registry
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of catheter shear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of catheter breakage due to catheter shear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean tension required to break the catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attempting weight loss
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of subjects with any polyp ≥6 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diagnostic yield of polyps ≥10 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity and specificity of CCE for polyps ≥6 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Myocardial infarction rates
Endpoint domain: Adverse events/effects
Primary endpoint: Bleeding rates (Bleeding Academic Research Consortium ≥2)
Endpoint domain: Adverse events/effects
Primary endpoint: Viral infectivity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: grade ≥3 diarrhoea
Endpoint domain: Adverse events/effects
Primary endpoint: grade ≥3 neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: new T1-hypointense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in ulcer area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SC peaks per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean SC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phosphorylation of S6K1Thr389
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phosphorylation of JNKThr183/Tyr185
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phosphorylation of SMAD2Ser245/250/255
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pure tone hearing threshold test values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total effective rates of ear stuffiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of mental health treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of units transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of women requiring additional packed red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Posttransfusion hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: axillary erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: door-to-puncture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction score of neurointerventionalist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of liver dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: disease activity
Endpoint domain: Physiological/clinical
Primary endpoint: OCT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LFM score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number of microbes on fingers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in management recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of anxiety/depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VL muscle architecture adaptations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of significant atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Stratum corneum moisture content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Need for oral steroid interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intentions to try e‐cigarettes in the future
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effects of ultrasound-guided HA injection on chronic plantar fasciitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute abundance of Lactobacillus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esophageal thermal injury (ETI)
Endpoint domain: Adverse events/effects
Primary endpoint: premature mortality effect estimates
Endpoint domain: Mortality/survival
Primary endpoint: Caregivers' perceived increase of parenting knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LNWT area ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of phonemes produced correctly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female Sexual Function Index (FSFI) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of vaginal smears with maturation index (VMI) >65
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease control (LDA/MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission/VLDA rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obesity stigma relating to personal responsibility and willpower
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of adequate hand positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VSS (Visual Scar Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCA-PSV values after meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to recommendations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Clinical remission by week 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in serum levels of C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants developing PPCS
Endpoint domain: Mortality/survival
Primary endpoint: Development of colonic polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean nasofrontal angle change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean nasolabial angle change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Simulation mean score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lung ultrasonography scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Confidence in managing a critically ill patient
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean heart rate change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in new diagnoses of infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Area over centre of pressure movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eyes reaching 20/25 Snellen best spectacle-corrected visual acuity (BSCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean reduction in the scoring of symptoms and signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital transfers in the last 90 days of life
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: overall pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure to achieve vaginal delivery or cesarean delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Primary stability (ITV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anteroposterior diameter and cross-sectional area at the levels of base of the tongue and soft palate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceptible color change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impaired physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of ED/POD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: net clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ischaemic risk
Endpoint domain: Adverse events/effects
Primary endpoint: Root Length (RL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root Area (RRA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apical Diameter (AD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the classifier
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the classifier
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower-limb power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with the retained dorsal prepuce
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intraoperative anxiety of the doctors
Endpoint domain: Adverse events/effects
Primary endpoint: 48-h ischemic events reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: bleeding events increase
Endpoint domain: Adverse events/effects
Primary endpoint: total costs reduction
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of pain-free patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient commitment to a GP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of primary outcome in patients with acute kidney injury
Endpoint domain: Mortality/survival
Primary endpoint: V̇E/V̇CO2 slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work rate at ventilatory threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSMS and VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full clearance of warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric irritation
Endpoint domain: Adverse events/effects
Primary endpoint: Mean adjusted difference in 4-week preoperative 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthier immune cell gene expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Predictive response to Sertraline or Placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggression improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD-RS-5-HV-TS change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants reporting TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Patients alive with stoma in situ
Endpoint domain: Mortality/survival
Primary endpoint: dietary adherence
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Clinician empathic response rate to progress opportunities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinician empathic response rate to challenge opportunities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: pROM of the hip, knee, ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ5D3L index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Structural recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Surgical completeness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Addressing patients' spiritual concerns improved their mental and physical health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HOOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sEMG amplitude of Sternocleidomastoid muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sEMG amplitude of Upper Trapezius muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatigue levels of neck and craniofacial muscles
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: PCA bolus demands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative PCA dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for uterine cramping pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of serious adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse Pregnancy Outcomes (APOs)
Endpoint domain: Mortality/survival
Primary endpoint: mean peak diastolic mitral annular velocity (e')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: indexed left atrial volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: right ventricular e"
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevention of moderate-to-severe exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maternal postnatal depression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infant's morbidity at postnatal 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician adherence to guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean antibiotic prescription duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worsening heart failure at day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin A AUC (retinyl palmitate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standardized uptake value ratio root-mean-square error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: correct amyloid status prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver strain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in stationary behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in light physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HAZ (Height-for-Age Z-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentially expressed genes (DEGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of burnout
Endpoint domain: Adverse events/effects
Primary endpoint: HECSI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete and timely receipt of all recommended vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived relative harm to health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived risk of decreased lung function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived risk of heart attack
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: functional NYHA class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ototoxic hearing loss
Endpoint domain: Adverse events/effects
Primary endpoint: annual decline in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: moderate or severe paravalvular leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of suffering
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in FACIT-Sp-12 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of endoscopic re‐intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: severe ROP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: distance covered during the 2-minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting Blood Glucose (FPG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post Prandial Glycaemia (PPG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight and BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute mean O2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total time at >90% O2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: migraine disability (MIDAS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MS Pain (PES) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically meaningful fatigue reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Odds of GHQ-12 caseness
Endpoint domain: Adverse events/effects
Primary endpoint: daily methadone dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stated intent to vaccinate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follow-up assessment completion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of symptomatic lymphoceles
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of lymphoceles requiring intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Discontinuations due to treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Nursing satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dietary Diversity Score (DDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Six Food Group Pyramid (SFG) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Retention in care at 12 months postpartum
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean VSQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FSFI scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VLQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CR rate in the acute phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualification rate of blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of recovery from Bell's palsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of HLA-Bw4 ligand
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes